Cite
HARVARD Citation
Maggi, C. et al. (n.d.). 2366 Metronomic capecitabine and bevacizumab is an active combination in patients with relapsed peritoneal pseudomyxoma. European journal of cancer. pp. S458-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maggi, C. et al. (n.d.). 2366 Metronomic capecitabine and bevacizumab is an active combination in patients with relapsed peritoneal pseudomyxoma. European journal of cancer. pp. S458-. [Online].